13F Filings History of BRAIDWELL LP

Latest 13F report
Q4 2025 - 17 Feb 2026
Value $
$3,126,999,740
Signature - Title
Ken Joseph - Chief Compliance Officer
Location
Stamford, CT
Summary
This page shows a list of all the recent 13F filings made by BRAIDWELL LP. Form 13F is required to be filed within 45 days of the end of a calendar quarter. BRAIDWELL LP reported 73 stock holdings with total value $3,126,999,740 as of Q4 2025. Top holdings included CAI, GUARDANT HEALTH INC, EWTX, REPLIGEN CORP, and NBIX.

Follow Filing Activity

Follow BRAIDWELL LP and return when a new 13F portfolio filing appears.

This tracks SEC filing changes for this page using existing product update flows.

Sign up to follow filing activity
Holdings Value

Sponsored

Quick Takeaways

  • BRAIDWELL LP reports institutional holdings through Form 13F filings.
  • Latest reported quarter: Q4 2025.
  • Latest reported holdings value: $3,126,999,740.

What Changed

  • Most recent filing was accepted on 17 Feb 2026, 17:12.
  • Reported value moved from $3,370,348,920 to $3,126,999,740.

Why This Matters

  • This gives a plain-language read of holdings direction before you open full quarter tables.
  • Use the filing links below to verify the exact SEC source document.

Official SEC Source

Backed by Form 13F

Portfolio holdings and changes are grounded in SEC Form 13F filings.

See Original Filing
Quarter Holdings Value $ Bought Sold Net Top Holdings Form Type Filing Time
Q4 2025 73 $3,126,999,740 +$722,490,100 -$1,480,181,233 -$757,691,133 CAI, GUARDANT HEALTH INC, EWTX, REPLIGEN CORP, NBIX 13F-HR 17 Feb 2026, 17:12
Q3 2025 73 $3,370,348,920 +$737,465,023 -$575,050,783 +$162,414,240 GUARDANT HEALTH INC, CAI, NOVOCURE LTD, XENE, CGON 13F-HR 14 Nov 2025, 16:07
Q2 2025 55 $2,923,924,032 +$499,741,109 -$570,956,679 -$71,215,570 GUARDANT HEALTH INC, CAI, NBIX, NOVOCURE LTD, XENE 13F-HR 14 Aug 2025, 16:34
Q1 2025 64 $2,844,802,567 +$846,348,550 -$1,118,782,305 -$272,433,755 GUARDANT HEALTH INC, NOVOCURE LTD, NBIX, LEGN, REPLIGEN CORP 13F-HR 15 May 2025, 16:34
Q4 2024 73 $3,372,652,431 +$584,985,822 -$597,705,270 -$12,719,448 GUARDANT HEALTH INC, BRIDGEBIO PHARMA INC, NOVOCURE LTD, NBIX, REPLIGEN CORP 13F-HR 14 Feb 2025, 16:18
Q3 2024 81 $3,527,985,574 +$699,942,636 -$551,185,675 +$148,756,961 GUARDANT HEALTH INC, BRIDGEBIO PHARMA INC, NOVOCURE LTD, CGON, NUVASIVE INC 13F-HR 14 Nov 2024, 16:22
Q2 2024 75 $3,187,767,909 +$925,413,405 -$688,113,088 +$237,300,317 GUARDANT HEALTH INC, BRIDGEBIO PHARMA INC, NOVOCURE LTD, NUVASIVE INC, NBIX 13F-HR 14 Aug 2024, 16:29
Q1 2024 70 $3,102,773,641 +$917,098,241 -$612,267,221 +$304,831,020 GUARDANT HEALTH INC, BRIDGEBIO PHARMA INC, EXACT SCIENCES CORP, NOVOCURE LTD, APGE 13F-HR 15 May 2024, 16:26
Q4 2023 72 $2,722,670,757 +$374,961,295 -$1,014,613,338 -$639,652,043 GUARDANT HEALTH INC, BRIDGEBIO PHARMA INC, ASCENDIS PHARMA A/S, EXACT SCIENCES CORP, NOVOCURE LTD 13F-HR 14 Feb 2024, 16:37
Q3 2023 85 $3,164,360,709 +$710,756,067 -$423,382,214 +$287,373,853 GUARDANT HEALTH INC, NOVOCURE LTD, ASCENDIS PHARMA A/S, EXACT SCIENCES CORP, NANOSTRING TECHNOLOGIES INC 13F-HR 14 Nov 2023, 16:36
Q2 2023 81 $3,060,428,640 +$589,173,408 -$680,885,126 -$91,711,718 GUARDANT HEALTH INC, EXACT SCIENCES CORP, NOVOCURE LTD, NANOSTRING TECHNOLOGIES INC, ASCENDIS PHARMA A/S 13F-HR 14 Aug 2023, 16:29
Q1 2023 81 $2,924,706,963 +$463,204,594 -$495,570,711 -$32,366,117 GUARDANT HEALTH INC, EXACT SCIENCES CORP, NANOSTRING TECHNOLOGIES INC, NOVOCURE LTD, ALPHATEC HLDGS INC 13F-HR 15 May 2023, 17:18
Q4 2022 88 $2,946,459,579 $0 $0 $0 GUARDANT HEALTH INC, NANOSTRING TECHNOLOGIES INC, NOVOCURE LTD, EXACT SCIENCES CORP, ALPHATEC HLDGS INC 13F-HR 14 Feb 2023, 16:27

Sponsored